Erratum to ‘B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin α2β1-mediated FAK and AKT activation’ (JHEP Reports 5 [2023] 100903)

Yao Tang,Zhijie Xu,Fuyuan Xu,Juan Ye,Jianxu Chen,Jianzhong He,Yingchun Chen,Chunhui Qi,Hongbin Huang,Ruiyang Liu,Hong Shan,Fei Xiao

DOI: https://doi.org/10.1016/j.jhepr.2024.101042

IF: 9.917

2024-01-01

JHEP Reports

Abstract:[This corrects the article DOI: 10.1016/j.jhepr.2023.100903.].

What problem does this paper attempt to address?

Erratum to "Characterization of a predictive signature for tumor microenvironment and immunotherapy response in hepatocellular carcinoma involving neutrophil extracellular traps" [Heliyon Volume 10, issue 10, May 2024, article e30827]

Ziwei Yuan,Xuejia Yang,Zujian Hu,Yuanyuan Gao,Penghua Yan,Fan Zheng,Yangyang Guo,Xiaowu Wang,Jingzong Zhou

DOI: https://doi.org/10.1016/j.heliyon.2024.e33955

IF: 3.776

2024-07-02

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2024.e30827.].
Author Correction to ‘FGF4 Protects the Liver from Immune-Mediated Injury by Activating CaMKKβ-PINK1 Signal Pathway to Inhibit Hepatocellular Apoptosis’ [acta Pharmaceutica Sinica B 14(2024)1605-1623]

Zhifeng Huang,Tongtong Pan,Liang Xu,Lu Shi,Xiong Ma,Liya Zhou,Luyao Wang,Jiaojiao Wang,Guoqing Zhu,Dazhi Chen,Lingtao Song,Xiaomin Pan,Xiaodong Wang,Xiaokun Li,Yongde Luo,Yongping Chen

DOI: https://doi.org/10.1016/j.apsb.2024.04.008

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2023.12.012.].
Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients

Ping Chen,Haolin Song,Xu Wang,J. Guo,Jianfei Wang,Jianhua Zhou,Xiaohong Kang,Chaolei Jin,Yubo Cai,Zixuan Feng,Hainv Gao,Fang Lü,Lanjuan Li

DOI: https://doi.org/10.3389/fonc.2023.1170066

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1037742.].
Erratum: Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway: Erratum.

Xing Qin,Ming Yan,Xu Wang,Qin Xu,Xiaoning Wang,Xueqin Zhu,Jianbo Shi,Zhihui Li,Jianjun Zhang,Wantao Chen

DOI: https://doi.org/10.7150/thno.69175

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.22182.].
Erratum: CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum.

Yan-Ming Liu,Yue Cao,Ping-Sen Zhao,Liang-Yin Wu,Ya-Min Lu,Yu-Long Wang,Jia-Feng Zhao,Xin-Guang Liu

DOI: https://doi.org/10.7150/ijbs.72651

2022-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.66915.].
EPHB4 Regulates the Proliferation and Metastasis of Oral Squamous Cell Carcinoma through the HMGB1/NF-κB Signalling Pathway: Erratum

Chen Yi,Xiliu Zhang,Hongyu Li,Guanhui Chen,Binghui Zeng,Yiming Li,Chao Wang,Yi He,Xun Chen,Zixian Huang,Dongsheng Yu

DOI: https://doi.org/10.7150/jca.87278

IF: 3.9

2023-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.59331.].

oncology
Erratum: Author correction to "The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304].

Geni Ye,Maohua Huang,Yong Li,Jie Ouyang,Minfeng Chen,Qing Weng,Xiaobo Li,Huhu Zeng,Pei Long,Zepei Fan,Junqiang Yin,Wencai Ye,Dongmei Zhang

DOI: https://doi.org/10.1016/j.apsb.2022.12.020

2023-01-01

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.08.015.].
Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Pengzhao Shang,Rui Gao,Yijia Zhu,Xiaorui Zhang,Yang Wang,Minji Guo,Hui Peng,Min Wang,Juan Zhang

DOI: https://doi.org/10.1016/j.apsb.2024.02.014

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Junfeng Zhang,Wei Xue,Kai Xu,Liang Yi,Yu Guo,Tian Xie,Haipeng Tong,Bo Zhou,Shunan Wang,Qing Li,Heng Liu,Xiao Chen,Jingqin Fang,Weiguo Zhang

DOI: https://doi.org/10.7150/thno.92042

IF: 11.6

2023-11-17

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44427.].
Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway: Erratum

Xing Qin,Ming Yan,Xu Wang,Qin Xu,Xiaoning Wang,Xueqin Zhu,Jianbo Shi,Zhihui Li,Jianjun Zhang,Wantao Chen

DOI: https://doi.org/10.7150/thno.69175

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.22182.].

medicine, research & experimental
Erratum: ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]

DOI: https://doi.org/10.2147/OTT.S390829

2022-09-27

Abstract:[This corrects the article DOI: 10.2147/OTT.S302028.].
Erratum: "Toward improved models of human cancer" [APL Bioeng. 5, 010901 (2021)]

Bryan E Welm,Christos Vaklavas,Alana L Welm

DOI: https://doi.org/10.1063/5.0057199

2021-06-02

Abstract:[This corrects the article DOI: 10.1063/5.0030534.].
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC

Xiao Wang,Chao Liang,Xin Yao,Ruo-Han Yang,Zhan-Sheng Zhang,Fan-Ye Liu,Wen-Qi Li,Shu-Hua Pei,Jing Ma,Song-Qiang Xie,Dong Fang

DOI: https://doi.org/10.3389/fphar.2021.724799

IF: 5.6

2021-07-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.577108.].

pharmacology & pharmacy
The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum

Liu Yang,Yang Guo,Xin Liu,Tongtong Wang,Xiangmin Tong,Kefeng Lei,Jiahui Wang,Dongsheng Huang,Qiuran Xu

DOI: https://doi.org/10.7150/jca.76866

IF: 3.9

2022-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.25569.].

oncology
Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA

Wendong Yang,Zhongwei Li,Rong Qin,Xiaorui Wang,Huihui An,Yule Wang,Yan Zhu,Yantao Liu,Shijiao Cai,Shuang Chen,Tao Sun,Jing Meng,Cheng Yang

DOI: https://doi.org/10.3389/fonc.2021.828861

IF: 4.7

2022-01-13

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.01187.].

oncology
Author Correction to “TMEM16A Inhibits Angiotensin II-induced Basilar Artery Smooth Muscle Cell Migration in a WNK1-dependent Manner” [acta Pharm Sin B 11(12) (2021) 3994–4007]

Huaqing Zheng,Xiaolong Li,Xin Zeng,Chengcui Huang,Mingming Ma,Xiaofei Lv,Yajuan Zhang,Lu Sun,Guanlei Wang,Yanhua Du,Yongyuan Guan

DOI: https://doi.org/10.1016/j.apsb.2023.01.001

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.04.013.].
Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Wan Li,Liwen Ren,Xiangjin Zheng,Jinyi Liu,Jinhua Wang,Tengfei Ji,Guanhua Du

DOI: https://doi.org/10.1016/j.apsb.2024.04.025

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2019.12.012.].
Correction: Cui, H., et al. BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation. Int. J. Mol. Sci. 2019, 20, 4062

Herong Cui,Wenbo Guo,Beibei Zhang,Guoping Li,Tong Li,Yanyan Yuan,Na Zhang,Yuwei Yang,Wuwen Feng,Fuhao Chu,Shenglan Wang,Bing Xu,Penglong Wang,Haimin Lei

DOI: https://doi.org/10.3390/ijms21186814

IF: 5.6

2020-09-17

International Journal of Molecular Sciences

Abstract:The authors wish to make the following corrections to this paper [...]

biochemistry & molecular biology,chemistry, multidisciplinary
Erratum: circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis: Erratum.

Huan Liu,Guanghui Hu,Zaoyu Wang,Qunlong Liu,Jin Zhang,Yonghui Chen,Yiran Huang,Wei Xue,Yunfei Xu,Wei Zhai

DOI: https://doi.org/10.7150/thno.69378

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.47239.].

Erratum to ‘B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin α2β1-mediated FAK and AKT activation’ (JHEP Reports 5 [2023] 100903)

Erratum to "Characterization of a predictive signature for tumor microenvironment and immunotherapy response in hepatocellular carcinoma involving neutrophil extracellular traps" [Heliyon Volume 10, issue 10, May 2024, article e30827]

Author Correction to ‘FGF4 Protects the Liver from Immune-Mediated Injury by Activating CaMKKβ-PINK1 Signal Pathway to Inhibit Hepatocellular Apoptosis’ [acta Pharmaceutica Sinica B 14(2024)1605-1623]

Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients

Erratum: Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway: Erratum.

Erratum: CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum.

EPHB4 Regulates the Proliferation and Metastasis of Oral Squamous Cell Carcinoma through the HMGB1/NF-κB Signalling Pathway: Erratum

Erratum: Author correction to "The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304].

Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway: Erratum

Erratum: ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]

Erratum: "Toward improved models of human cancer" [APL Bioeng. 5, 010901 (2021)]

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC

The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum

Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA

Author Correction to “TMEM16A Inhibits Angiotensin II-induced Basilar Artery Smooth Muscle Cell Migration in a WNK1-dependent Manner” [acta Pharm Sin B 11(12) (2021) 3994–4007]

Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Correction: Cui, H., et al. BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation. Int. J. Mol. Sci. 2019, 20, 4062

Erratum: circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis: Erratum.